XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Oct. 24, 2020
Oct. 26, 2019
Cash flows from operating activities    
Net income $ 39,983 $ 40,892
Adjustments to reconcile net income to cash provided by (used for) operating activities    
(Gain)/loss on disposal of assets 140 (283)
Gain on sale of investments (284) (99)
Change in deferred taxes 1,849 273
Provision for doubtful accounts (1,568) 350
Depreciation and amortization 16,351 14,936
Equity-based compensation expense 6,167 4,707
Change in receivables (28,949) (12,722)
Change in inventories (3,511) (7,645)
Change in right-of-use lease assets 35,137 32,323
Change in other assets (1,926) (4,088)
Change in payables 33,236 3,854
Change in lease liabilities (32,422) (32,665)
Change in other liabilities 131,507 13,869
Net cash provided by operating activities 195,710 53,702
Cash flows from investing activities    
Proceeds from disposals of assets 21 88
Proceeds from insurance 0 1,018
Capital expenditures (15,442) (22,949)
Purchases of investments (17,649) (17,798)
Proceeds from sales of investments 19,470 13,171
Acquisitions (7,783) (5,875)
Net cash used for investing activities (21,383) (32,345)
Cash flows from financing activities    
Payments on debt and finance lease liabilities (75,013) (95)
Stock issued for stock and employee benefit plans, net of shares withheld for taxes 364 571
Purchases of common stock 0 (23,167)
Dividends paid to shareholders (3,216) (12,151)
Dividends paid to minority interest joint venture partners [1] (8,507) 0
Net cash used for financing activities (86,372) (34,842)
Effect of exchange rate changes on cash and equivalents 1,944 1,239
Change in cash, cash equivalents and restricted cash 89,899 (12,246)
Cash, cash equivalents and restricted cash at beginning of period 263,528 131,787
Cash, cash equivalents and restricted cash at end of period 353,427 119,541
Supplemental disclosure of non-cash investing activities    
Capital expenditures included in payables $ 3,769 $ 5,805
[1] Includes dividends paid to joint venture minority partners resulting from the repatriation of dividends from our foreign earnings that we no longer consider permanently reinvested.